# Origin Bancorp, Inc.: financial statements, quarterly

OBK · TXSE · CIK 1516912 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/obk.md) · [Financials](/companies/obk/financials.md) · [Filings](/companies/obk/filings.md) · [Insiders](/companies/obk/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/obk/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [61.3](/filings/0001516912-23-000175.md) | [62.5 d](/filings/0001516912-25-000061.md) | [65.4](/filings/0001516912-24-000040.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [5.8](/filings/0001516912-24-000117.md) | [4.1 d](/filings/0001516912-26-000011.md) | [6.2](/filings/0001516912-25-000081.md) | [5.7](/filings/0001516912-25-000132.md) | [5.1](/filings/0001516912-25-000150.md) | [3.7 d](/filings/0001516912-26-000011.md) | [6.1](/filings/0001516912-26-000032.md) | [4.0](/filings/0001516912-26-000046.md) | [2.4](/filings/0001516912-25-000150.md) | [7.9 d](/filings/0001516912-26-000011.md) | [7.6](/filings/0001516912-26-000032.md) | [9.3](/filings/0001516912-26-000046.md) |
| Net income | $m | [24.3](/filings/0001516912-24-000117.md) | [13.4 d](/filings/0001516912-26-000011.md) | [22.6](/filings/0001516912-25-000150.md) | [21.0](/filings/0001516912-25-000150.md) | [18.6](/filings/0001516912-25-000150.md) | [14.3 d](/filings/0001516912-26-000011.md) | [22.4](/filings/0001516912-26-000046.md) | [14.6](/filings/0001516912-26-000046.md) | [8.6](/filings/0001516912-25-000150.md) | [29.5 d](/filings/0001516912-26-000011.md) | [27.7](/filings/0001516912-26-000046.md) | [33.8](/filings/0001516912-26-000046.md) |
| Diluted EPS | $ per share | [0.79](/filings/0001516912-24-000117.md) | not reported | [0.73](/filings/0001516912-25-000081.md) | [0.67](/filings/0001516912-25-000132.md) | [0.60](/filings/0001516912-25-000150.md) | not reported | [0.71](/filings/0001516912-26-000032.md) | [0.47](/filings/0001516912-26-000046.md) | [0.27](/filings/0001516912-25-000150.md) | not reported | [0.89](/filings/0001516912-26-000032.md) | [1.09](/filings/0001516912-26-000046.md) |
| Basic EPS | $ per share | [0.79](/filings/0001516912-24-000117.md) | not reported | [0.73](/filings/0001516912-25-000081.md) | [0.68](/filings/0001516912-25-000132.md) | [0.60](/filings/0001516912-25-000150.md) | not reported | [0.72](/filings/0001516912-26-000032.md) | [0.47](/filings/0001516912-26-000046.md) | [0.28](/filings/0001516912-25-000150.md) | not reported | [0.89](/filings/0001516912-26-000032.md) | [1.10](/filings/0001516912-26-000046.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.3](/filings/0001516912-23-000175.md) | [0.3](/filings/0001516912-25-000064.md) | [0.3](/filings/0001516912-24-000040.md) | [0.3](/filings/0001516912-24-000092.md) | [0.3](/filings/0001516912-24-000117.md) | [0.5](/filings/0001516912-26-000011.md) | [0.5](/filings/0001516912-25-000081.md) | [0.3](/filings/0001516912-25-000132.md) | [0.6](/filings/0001516912-25-000150.md) | [0.4](/filings/0001516912-26-000046.md) | [0.7](/filings/0001516912-26-000032.md) | [0.5](/filings/0001516912-26-000046.md) |
| Total assets | $bn | [9.7](/filings/0001516912-23-000175.md) | [9.7](/filings/0001516912-25-000064.md) | [9.9](/filings/0001516912-24-000040.md) | [9.9](/filings/0001516912-24-000092.md) | [10.0](/filings/0001516912-24-000117.md) | [9.7](/filings/0001516912-26-000011.md) | [9.8](/filings/0001516912-25-000081.md) | [9.7](/filings/0001516912-25-000132.md) | [9.8](/filings/0001516912-25-000150.md) | [9.7](/filings/0001516912-26-000046.md) | [10.2](/filings/0001516912-26-000032.md) | [10.3](/filings/0001516912-26-000046.md) |
| Total liabilities | $bn | [8.7](/filings/0001516912-23-000175.md) | [8.7](/filings/0001516912-25-000064.md) | [8.8](/filings/0001516912-24-000040.md) | [8.9](/filings/0001516912-24-000092.md) | [8.8](/filings/0001516912-24-000117.md) | [8.5](/filings/0001516912-26-000011.md) | [8.6](/filings/0001516912-25-000081.md) | [8.5](/filings/0001516912-25-000132.md) | [8.6](/filings/0001516912-25-000150.md) | [8.5](/filings/0001516912-26-000046.md) | [8.9](/filings/0001516912-26-000032.md) | [9.0](/filings/0001516912-26-000046.md) |
| Shareholders' equity | $bn | [1.0](/filings/0001516912-24-000117.md) | [1.1](/filings/0001516912-26-000011.md) | [1.1](/filings/0001516912-25-000150.md) | [1.1](/filings/0001516912-25-000150.md) | [1.1](/filings/0001516912-25-000150.md) | [1.1](/filings/0001516912-26-000046.md) | [1.2](/filings/0001516912-26-000046.md) | [1.2](/filings/0001516912-26-000046.md) | [1.2](/filings/0001516912-25-000150.md) | [1.2](/filings/0001516912-26-000046.md) | [1.3](/filings/0001516912-26-000046.md) | [1.3](/filings/0001516912-26-000046.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [25.3 d](/filings/0001516912-24-000117.md) | [29.4 d](/filings/0001516912-26-000011.md) | [27.1](/filings/0001516912-25-000081.md) | [11.9 d](/filings/0001516912-25-000132.md) | [39.6 d](/filings/0001516912-25-000150.md) | [29.9 d](/filings/0001516912-26-000011.md) | [35.6](/filings/0001516912-26-000032.md) | [20.6 d](/filings/0001516912-26-000046.md) | [59.3 d](/filings/0001516912-25-000150.md) | [43.4 d](/filings/0001516912-26-000011.md) | [52.9](/filings/0001516912-26-000032.md) | [40.0 d](/filings/0001516912-26-000046.md) |
| Capital expenditure | $m | [8.3 d](/filings/0001516912-24-000117.md) | [9.3 d](/filings/0001516912-26-000011.md) | [3.9](/filings/0001516912-25-000081.md) | [5.4 d](/filings/0001516912-25-000132.md) | [7.3 d](/filings/0001516912-25-000150.md) | [5.4 d](/filings/0001516912-26-000011.md) | [0.8](/filings/0001516912-26-000032.md) | [1.0 d](/filings/0001516912-26-000046.md) | [2.5 d](/filings/0001516912-25-000150.md) | [3.6 d](/filings/0001516912-26-000011.md) | [5.0](/filings/0001516912-26-000032.md) | [9.2 d](/filings/0001516912-26-000046.md) |
| Dividends paid | $m | [4.7 d](/filings/0001516912-24-000117.md) | [4.7 d](/filings/0001516912-26-000011.md) | [4.7](/filings/0001516912-25-000081.md) | [4.7 d](/filings/0001516912-25-000132.md) | [4.7 d](/filings/0001516912-25-000150.md) | [4.7 d](/filings/0001516912-26-000011.md) | [4.8](/filings/0001516912-26-000032.md) | [4.7 d](/filings/0001516912-26-000046.md) | [4.7 d](/filings/0001516912-25-000150.md) | [4.7 d](/filings/0001516912-26-000011.md) | [4.7](/filings/0001516912-26-000032.md) | [7.8 d](/filings/0001516912-26-000046.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | [0.0 d](/filings/0001516912-25-000150.md) | [0.0 d](/filings/0001516912-26-000011.md) | [0.0](/filings/0001516912-26-000032.md) | [4.4 d](/filings/0001516912-26-000046.md) | [9.5 d](/filings/0001516912-25-000150.md) | [1.9 d](/filings/0001516912-26-000011.md) | [6.8](/filings/0001516912-26-000032.md) | [10.1 d](/filings/0001516912-26-000046.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [28.5](/filings/0001516912-23-000175.md) | [30.9](/filings/0001516912-24-000040.md) | [30.9](/filings/0001516912-24-000092.md) | [30.9](/filings/0001516912-24-000117.md) | [31.1](/filings/0001516912-25-000081.md) | [31.1](/filings/0001516912-25-000132.md) | [31.2](/filings/0001516912-25-000150.md) | [31.4](/filings/0001516912-26-000032.md) | [31.3](/filings/0001516912-26-000046.md) | [31.4](/filings/0001516912-25-000150.md) | [31.2](/filings/0001516912-26-000032.md) | [31.2](/filings/0001516912-26-000046.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 30,849,678 at 2026-07-31, from the cover of the [10-Q filed 2026-08-05](/filings/0001516912-26-000046.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:41 ET. No prices; not investment advice.